| Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients V Chernyak, KJ Fowler, A Kamaya, AZ Kielar, KM Elsayes, MR Bashir, ... Radiology 289 (3), 816-830, 2018 | 1196 | 2018 |
| Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial SA Harrison, MR Bashir, CD Guy, R Zhou, CA Moylan, JP Frias, ... The Lancet 394 (10213), 2012-2024, 2019 | 864 | 2019 |
| Deep learning in radiology: An overview of the concepts and a survey of the state of the art with focus on MRI MA Mazurowski, M Buda, A Saha, MR Bashir Journal of magnetic resonance imaging 49 (4), 939-954, 2019 | 751 | 2019 |
| NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial SA Harrison, ME Rinella, MF Abdelmalek, JF Trotter, AH Paredes, ... The Lancet 391 (10126), 1174-1185, 2018 | 472 | 2018 |
| Emerging applications for ferumoxytol as a contrast agent in MRI MR Bashir, L Bhatti, D Marin, RC Nelson Journal of Magnetic Resonance Imaging 41 (4), 884-898, 2015 | 442 | 2015 |
| Gadolinium‐based contrast agents: a comprehensive risk assessment TJ Fraum, DR Ludwig, MR Bashir, KJ Fowler Journal of Magnetic Resonance Imaging 46 (2), 338-353, 2017 | 440 | 2017 |
| Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis T Yokoo, SD Serai, A Pirasteh, MR Bashir, G Hamilton, D Hernando, ... Radiology 286 (2), 486-498, 2018 | 404 | 2018 |
| Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial SA Harrison, R Taub, GW Neff, KJ Lucas, D Labriola, SE Moussa, ... Nature medicine 29 (11), 2919-2928, 2023 | 396 | 2023 |
| Current and potential imaging applications of ferumoxytol for magnetic resonance imaging GB Toth, CG Varallyay, A Horvath, MR Bashir, PL Choyke, ... Kidney international 92 (1), 47-66, 2017 | 367 | 2017 |
| Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy—a … CB Van der Pol, CS Lim, CB Sirlin, TA McGrath, JP Salameh, MR Bashir, ... Gastroenterology 156 (4), 976-986, 2019 | 362 | 2019 |
| Evidence supporting LI-RADS major features for CT-and MR imaging–based diagnosis of hepatocellular carcinoma: a systematic review A Tang, MR Bashir, MT Corwin, I Cruite, CF Dietrich, RKG Do, EC Ehman, ... Radiology 286 (1), 29-48, 2018 | 347 | 2018 |
| Liver fat quantification using a multi‐step adaptive fitting approach with multi‐echo GRE imaging X Zhong, MD Nickel, SAR Kannengiesser, BM Dale, B Kiefer, MR Bashir Magnetic resonance in medicine 72 (5), 1353-1365, 2014 | 314 | 2014 |
| Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage MS Siddiqui, G Yamada, R Vuppalanchi, M Van Natta, R Loomba, C Guy, ... Clinical gastroenterology and hepatology 17 (9), 1877-1885. e5, 2019 | 304 | 2019 |
| Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic … MS Middleton, ER Heba, CA Hooker, MR Bashir, KJ Fowler, ... Gastroenterology 153 (3), 753-761, 2017 | 294 | 2017 |
| NGM282 improves liver fibrosis and histology in 12 weeks in patients with nonalcoholic steatohepatitis SA Harrison, SJ Rossi, AH Paredes, JF Trotter, MR Bashir, CD Guy, ... Hepatology 71 (4), 1198-1212, 2020 | 293 | 2020 |
| Efficacy and safety of aldafermin, an engineered FGF19 analog, in a randomized, double-blind, placebo-controlled trial of patients with nonalcoholic steatohepatitis SA Harrison, G Neff, CD Guy, MR Bashir, AH Paredes, JP Frias, Z Younes, ... Gastroenterology 160 (1), 219-231. e1, 2021 | 291 | 2021 |
| A North American expert opinion statement on sarcopenia in liver transplantation EJ Carey, JC Lai, C Sonnenday, EB Tapper, P Tandon, A Duarte‐Rojo, ... Hepatology 70 (5), 1816-1829, 2019 | 280 | 2019 |
| 2017 version of LI-RADS for CT and MR imaging: an update KM Elsayes, JC Hooker, MM Agrons, AZ Kielar, A Tang, KJ Fowler, ... Radiographics 37 (7), 1994-2017, 2017 | 276 | 2017 |
| Safety and technique of ferumoxytol administration for MRI SS Vasanawala, KL Nguyen, MD Hope, MD Bridges, TA Hope, ... Magnetic resonance in medicine 75 (5), 2107-2111, 2016 | 233 | 2016 |
| Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition JA Pietryga, LMB Burke, D Marin, TA Jaffe, MR Bashir Radiology 271 (2), 426-434, 2014 | 205 | 2014 |
Claude SirlinLiver Imaging Group, Dept of Radiology, UC San DiegoVerified email at ucsd.edu
